| A novel analgesic isolated from a traditional Chinese medicine Y Zhang, C Wang, L Wang, GS Parks, X Zhang, Z Guo, Y Ke, KW Li, ... Current Biology 24 (2), 117-123, 2014 | 107 | 2014 |
| Recent updates on the melanin-concentrating hormone (MCH) and its receptor system: lessons from MCH1R antagonists S Chung, GS Parks, C Lee, O Civelli Journal of Molecular Neuroscience 43, 115-121, 2011 | 82 | 2011 |
| The melanin-concentrating hormone (MCH) system in an animal model of depression-like behavior MJ Garcia-Fuster, GS Parks, SM Clinton, SJ Watson, H Akil, O Civelli European Neuropsychopharmacology 22 (8), 607-613, 2012 | 74 | 2012 |
| Histamine inhibits the melanin‐concentrating hormone system: implications for sleep and arousal GS Parks, ND Olivas, T Ikrar, NM Sanathara, L Wang, Z Wang, O Civelli, ... The Journal of physiology 592 (10), 2183-2196, 2014 | 51 | 2014 |
| Identification of neuropeptide receptors expressed by melanin‐concentrating hormone neurons GS Parks, L Wang, Z Wang, O Civelli Journal of Comparative Neurology 522 (17), 3817-3833, 2014 | 35 | 2014 |
| Anatomical characterization of bombesin receptor subtype‐3 mRNA expression in the rodent central nervous system L Zhang, GS Parks, Z Wang, L Wang, M Lew, O Civelli Journal of Comparative Neurology 521 (5), 1020-1039, 2013 | 25 | 2013 |
| The dual hypocretin receptor antagonist almorexant is permissive for activation of wake-promoting systems GS Parks, DR Warrier, L Dittrich, MD Schwartz, JB Palmerston, TC Neylan, ... Neuropsychopharmacology 41 (4), 1144-1155, 2016 | 19 | 2016 |
| Anxiolytic effects of the MCH1R antagonist TPI 1361-17 C Lee, GS Parks, O Civelli Journal of Molecular Neuroscience 43, 132-137, 2011 | 17 | 2011 |
| Mice lacking melanin concentrating hormone 1 receptor are resistant to seizures GS Parks, SM Okumura, K Gohil, O Civelli Neuroscience letters 484 (2), 104-107, 2010 | 14 | 2010 |
| Novel neuropeptides as ligands of orphan G protein-coupled receptors Y Zhang, Z Wang, G Scott Parks, O Civelli Current pharmaceutical design 17 (25), 2626-2631, 2011 | 11 | 2011 |
| Solriamfetol Titration & AdministRaTion (START) in Patients With Narcolepsy MJ Thorpy, D Hyman, GS Parks, A Chen, C Foley, B Baldys, D Ito, ... Clinical Therapeutics 44 (10), 1356-1369, 2022 | 2 | 2022 |
| Solriamfetol titration and administration (START) in patients with obstructive sleep apnea: a retrospective chart review and hypothetical patient scenario H Singh, D Hyman, GS Parks, A Chen, C Foley, B Baldys, D Ito, ... Advances in Therapy 39 (9), 4359-4373, 2022 | 2 | 2022 |
| Determinants of adherence/persistence to positive airway pressure therapy in patients with obstructive sleep apnoea R Saad, VK Somers, GS Parks, D Pushkarna, MS Fazeli, J Black Sleep Medicine 100, S245-S246, 2022 | 1 | 2022 |
| A Real-World Study Assessing the Relationship Between Positive Airway Pressure Treatment, Excessive Daytime Sleepiness, and Patient Satisfaction in Obstructive Sleep Apnoea S Parthasarathy, D Hyman, J Doherty, R Saad, J Zhang, S Morris, ... Sleep Medicine 100, S237, 2022 | 1 | 2022 |
| 0970 Real-world Use of Solriamfetol for Excessive Daytime Sleepiness in Patients Reporting Anxiety or Depression U Kallweit, H Benes, L Burghaus, G Eglit, I Abeynayake, S Floam, G Parks, ... Sleep 47 (Supplement_1), A416-A416, 2024 | | 2024 |
| 1024 SURWEY: Treatment of Excessive Daytime Sleepiness with Solriamfetol: Initiation, Titration, and Outcomes G Parks, L Burghaus, G Eglit, I Abeynayake, S Floam, Y Winter Sleep 47 (Supplement_1), A440-A440, 2024 | | 2024 |
| 0634 Effects of Solriamfetol on Cognition on Patients with Excessive Daytime Sleepiness Associated with Narcolepsy Y Winter, G Mayer, H Benes, L Burghaus, G Eglit, I Abeynayake, S Floam, ... Sleep 47 (Supplement_1), A271-A271, 2024 | | 2024 |
| SURWEY Study of Solriamfetol: Initiation, Titration, Safety, Efficacy, and Follow-up Experience for Patients with OSA in Germany (P9-9.010) Y Winter, G Mayer, H Benes, L Burghaus, I Abeynayake, S Floam, H Kwak, ... Neurology 102 (17_supplement_1), 3468, 2024 | | 2024 |
| EMERGE Study: An Open-label Evaluation of the Efficacy and Safety of AXS-07 (MoSEIC™ meloxicam-rizatriptan) for Migraine in Adults with Prior Inadequate Response to an Oral … P McAllister, S Tepper, A Chhabra, C Streicher, G Parks, H Tabuteau Neurology 102 (17_supplement_1), 5476, 2024 | | 2024 |
| Solriamfetol Improves Cognitive Performance in Preclinical Models of Sleep Apnea and in a Randomized Placebo-controlled Study of Sleep Apnea Participants (SHARP)(P9-9.004) D Gozal, H Van Dongen, E Leary, G Parks, S Floam, H Tabuteau Neurology 102 (17_supplement_1), 5206, 2024 | | 2024 |
